Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...
New York’s Medicaid program lost an estimated $31.2 million in drug rebates due to rejected pharmacy encounter claims, ...
U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...
On the revenue side, PBMs get paid by insurance companies to secure rebates from drugmakers in exchange for favorable ...
Legislation that would realign the state’s Medicaid pharmacy benefit under a single state-contracted pharmacy benefit manager ...
The Prescription Drug Affordability Act would aim to stop pharmacy benefit managers, or PBMs, from “exploiting loopholes” to ...
A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...
CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...
The 340B Drug Pricing Program (340B Program) is no stranger to controversy. We have previously covered the ongoing contract pharmacy legal battles ...
The coinsurance amount is usually around 25% of a drug's price before any rebates or discounts negotiated by a pharmacy benefit manager (PBM) or health plan are applied. While rebates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback